Home
>
National Drug Code (NDC)
>
Carbidopa and Levodopa
Carbidopa and Levodopa - 0115-3922-02 - (CARBIDOPA and LEVODOPA)
Drug Information of Carbidopa and Levodopa
| Product NDC: | 0115-3922 |
| Proprietary Name: | Carbidopa and Levodopa |
| Non Proprietary Name: | CARBIDOPA and LEVODOPA |
| Active Ingredient(s): | 25; 100 mg/1; mg/1 & nbsp; CARBIDOPA and LEVODOPA |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Carbidopa and Levodopa
| Product NDC: | 0115-3922 |
| Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076521 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040514 |
Package Information of Carbidopa and Levodopa
| Package NDC: | 0115-3922-02 |
| Package Description: | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-3922-02) |
NDC Information of Carbidopa and Levodopa
| NDC Code | 0115-3922-02 |
| Proprietary Name | Carbidopa and Levodopa |
| Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-3922-02) |
| Product NDC | 0115-3922 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CARBIDOPA and LEVODOPA |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20040514 |
| Marketing Category Name | ANDA |
| Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Substance Name | CARBIDOPA; LEVODOPA |
| Strength Number | 25; 100 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA] |
